Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Pearlberg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Chemical Biology|March 24, 2004
Protein expression clone repositories for functional proteomicsJoseph Pearlberg, Joshua LaBaer
Contemporary Clinical Trials Communications|June 4, 2020
Let's get americans back to work againAmitabh Chandra, Robert Jackson, Alexander Karnal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell linesDorre A Grueneberg, Wenliang Li, Joan E Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cellsAmy Baldwin, Wenliang Li, Miranda Grace, et al.
Nature Protocols|December 17, 2009
Targeted mutagenesis in zebrafish using customized zinc-finger nucleasesJonathan E Foley, Morgan L Maeder, Joseph Pearlberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2011
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagyLaura Gonzalez-Malerva, Jaehong Park, Lihua Zou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2005
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell linesJeffrey A Engelman, Pasi A Jänne, Craig Mermel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: I. Comparing kinase requirements across various cell typesDorre A Grueneberg, Sebastien Degot, Joseph Pearlberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.
Journal of the National Cancer Institute|August 18, 2005
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutationsToru Mukohara, Jeffrey A Engelman, Nasser H Hanna, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Chemical Biology|March 24, 2004
Protein expression clone repositories for functional proteomicsJoseph Pearlberg, Joshua LaBaer
Contemporary Clinical Trials Communications|June 4, 2020
Let's get americans back to work againAmitabh Chandra, Robert Jackson, Alexander Karnal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell linesDorre A Grueneberg, Wenliang Li, Joan E Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cellsAmy Baldwin, Wenliang Li, Miranda Grace, et al.
Nature Protocols|December 17, 2009
Targeted mutagenesis in zebrafish using customized zinc-finger nucleasesJonathan E Foley, Morgan L Maeder, Joseph Pearlberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2011
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagyLaura Gonzalez-Malerva, Jaehong Park, Lihua Zou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2005
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell linesJeffrey A Engelman, Pasi A Jänne, Craig Mermel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: I. Comparing kinase requirements across various cell typesDorre A Grueneberg, Sebastien Degot, Joseph Pearlberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.
Journal of the National Cancer Institute|August 18, 2005
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutationsToru Mukohara, Jeffrey A Engelman, Nasser H Hanna, et al.
Pageof 2